東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Targeting lysine demethylases in can...

Yan, Qin.

Linked to FindBook

Google Book

Amazon

博客來

Targeting lysine demethylases in cancer and other human diseases

Record Type:	Electronic resources : Monograph/item
Title/Author:	Targeting lysine demethylases in cancer and other human diseases/ edited by Qin Yan.
other author:	Yan, Qin.
Published:	Cham :Springer International Publishing : : 2023.,
Description:	vii, 184 p. :ill., digital ;24 cm.
[NT 15003449]:	Chapter 1. Lysine demethylation in pathogenesis -- Chapter 2. Targeting the LSD1/KDM1 Family of Lysine Demethylases in Cancer and Other Human Diseases -- Chapter 3. KDM2 demethylases as drug targets -- Chapter 4. Role of histone demethylase KDM3 (JMJD1) in transcriptional regulation and cancer progression -- Chapter 5. KDM4 demethylases as drug targets -- Chapter 6. KDM5 lysine demethylases in pathogenesis, from basic science discovery to the clinic -- Chapter 7. Context-dependent functions of lysine demethylases in physiology and disease -- Chapter 8. KDM7 demethylases as drug targets.
Contained By:	Springer Nature eBook
Subject:	Lysine - Therapeutic use. -
Online resource:	https://doi.org/10.1007/978-3-031-38176-8
ISBN:	9783031381768

Targeting lysine demethylases in cancer and other human diseases
Targeting lysine demethylases in cancer and other human diseases[electronic resource] /edited by Qin Yan. - Cham :Springer International Publishing :2023. - vii, 184 p. :ill., digital ;24 cm. - Advances in experimental medicine and biology,v. 14332214-8019 ;. - Advances in experimental medicine and biology ;v. 1433..

Chapter 1. Lysine demethylation in pathogenesis -- Chapter 2. Targeting the LSD1/KDM1 Family of Lysine Demethylases in Cancer and Other Human Diseases -- Chapter 3. KDM2 demethylases as drug targets -- Chapter 4. Role of histone demethylase KDM3 (JMJD1) in transcriptional regulation and cancer progression -- Chapter 5. KDM4 demethylases as drug targets -- Chapter 6. KDM5 lysine demethylases in pathogenesis, from basic science discovery to the clinic -- Chapter 7. Context-dependent functions of lysine demethylases in physiology and disease -- Chapter 8. KDM7 demethylases as drug targets.

This book provides a comprehensive summary of our current knowledge on lysine demethylases, a class of epigenetic regulators. It takes the reader on an exciting journey spanning the past two decades, starting from the initial discovery and characterization of these enzymes and leading up to the development of their small molecule modulators. These modulators have shown promise in clinical trials and hold great potential to improve patient outcomes. The book captures the progress made in this field and highlights the significant advancements that have paved the way for potential therapeutic applications. The book covers a wide range of topics, spanning both basic biology and clinical implications associated with lysine demethylases. It offers a comprehensive historical and conceptual framework for the discovery and characterization of similar epigenetic enzymes or modulators. Chapter one serves as an introductory overview, providing insights into the general characteristics and functions of lysine demethylases. In subsequent chapters, specifically chapters two to eight, each major family of lysine demethylases is individually explored in depth. By providing in-depth insights into the functional aspects of these enzymes, the book allows readers to grasp their significance in regulating cellular processes and influencing pathogenesis. Moreover, the book goes beyond fundamental knowledge and also explores the development of diagnostic and therapeutic strategies related to lysine demethylases. It highlights the potential for utilizing these enzymes as therapeutic targets for the treatment of various diseases, including cancer and infectious diseases. Additionally, the book highlights future directions aimed at further unraveling the roles of lysine demethylases and translating these findings into the clinic.

ISBN: 9783031381768

Standard No.: 10.1007/978-3-031-38176-8doiSubjects--Topical Terms:

3665930
Lysine
--Therapeutic use.

LC Class. No.: QP562.L8

Dewey Class. No.: 615.35

Targeting lysine demethylases in cancer and other human diseases
LDR:03499nmm a2200337 a 4500 001 2334382
003 DE-He213
005 20230926132401.0
006 m d
007 cr nn 008maaau
008 240402s2023 sz s 0 eng d
020 $a 9783031381768 $q (electronic bk.)
020 $a 9783031381751 $q (paper)
024 7 $a 10.1007/978-3-031-38176-8 $2 doi
035 $a 978-3-031-38176-8
040 $a GP $c GP
041 0 $a eng
050 4 $a QP562.L8
072 7 $a MBGR $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MBGR $2 thema
082 0 4 $a 615.35 $2 23
090 $a QP562.L8 $b T185 2023
245 0 0 $a Targeting lysine demethylases in cancer and other human diseases $h [electronic resource] / $c edited by Qin Yan.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2023.
300 $a vii, 184 p. : $b ill., digital ; $c 24 cm.
490 1 $a Advances in experimental medicine and biology, $x 2214-8019 ; $v v. 1433
505 0 $a Chapter 1. Lysine demethylation in pathogenesis -- Chapter 2. Targeting the LSD1/KDM1 Family of Lysine Demethylases in Cancer and Other Human Diseases -- Chapter 3. KDM2 demethylases as drug targets -- Chapter 4. Role of histone demethylase KDM3 (JMJD1) in transcriptional regulation and cancer progression -- Chapter 5. KDM4 demethylases as drug targets -- Chapter 6. KDM5 lysine demethylases in pathogenesis, from basic science discovery to the clinic -- Chapter 7. Context-dependent functions of lysine demethylases in physiology and disease -- Chapter 8. KDM7 demethylases as drug targets.
520 $a This book provides a comprehensive summary of our current knowledge on lysine demethylases, a class of epigenetic regulators. It takes the reader on an exciting journey spanning the past two decades, starting from the initial discovery and characterization of these enzymes and leading up to the development of their small molecule modulators. These modulators have shown promise in clinical trials and hold great potential to improve patient outcomes. The book captures the progress made in this field and highlights the significant advancements that have paved the way for potential therapeutic applications. The book covers a wide range of topics, spanning both basic biology and clinical implications associated with lysine demethylases. It offers a comprehensive historical and conceptual framework for the discovery and characterization of similar epigenetic enzymes or modulators. Chapter one serves as an introductory overview, providing insights into the general characteristics and functions of lysine demethylases. In subsequent chapters, specifically chapters two to eight, each major family of lysine demethylases is individually explored in depth. By providing in-depth insights into the functional aspects of these enzymes, the book allows readers to grasp their significance in regulating cellular processes and influencing pathogenesis. Moreover, the book goes beyond fundamental knowledge and also explores the development of diagnostic and therapeutic strategies related to lysine demethylases. It highlights the potential for utilizing these enzymes as therapeutic targets for the treatment of various diseases, including cancer and infectious diseases. Additionally, the book highlights future directions aimed at further unraveling the roles of lysine demethylases and translating these findings into the clinic.
650 0 $a Lysine $x Therapeutic use. $3 3665930
650 0 $a Cancer $x Chemotherapy. $3 753516
650 0 $a Cancer $x Pathophysiology. $3 669249
650 1 4 $a Biomedical Research. $3 851895
700 1 $a Yan, Qin. $3 3665928
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer Nature eBook
830 0 $a Advances in experimental medicine and biology ; $v v. 1433. $3 3665929
856 4 0 $u https://doi.org/10.1007/978-3-031-38176-8
950 $a Biomedical and Life Sciences (SpringerNature-11642)